TPP talks bog down on US push for drug protections

Demonstrators protest in Atlanta, Georgia, where trade ministers from the US, Japan and 10 other Pacific Rim countries are trying to negotiate a final agreement on the Trans-Pacific Partnership trade agreement, on September 30, 2015The US demand for longer protections for biologic drugs bogged down talks on the Trans-Pacific Partnership for another day on Saturday. With the top-level negotiations to finalize the huge trade agreement already extended two days, Washington’s partners in the 12-country talks appeared to be stiffly resisting its push for much more than the five-year patent protections more widely accepted. The United States, which has a 12-year standard domestically to protect the creations of pharmaceutical companies, was said to be willing to compromise at eight years, but Australia, Chile and Peru at least have resisted the push.

Share this article